Inhibrx Biosciences, Inc.
A clinical-stage biopharma company developing biologic therapeutics for oncology.
INBX | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 11025 N. TORREY PINES ROAD, SUITE 140, 92037 LA JOLLA
- Website:
- https://inhibrx.com/
- Sector:
- Manufacturing
Description
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing novel biologic therapeutics for patients with life-threatening conditions. The company leverages its expertise in protein engineering and an understanding of target biology to advance a pipeline of therapeutic candidates. Its clinical programs are focused on oncology, with lead trials covering cancers such as sarcoma, chondrosarcoma, and head and neck cancer. A key candidate in its pipeline is ozekibart (INBRX-109), a tetravalent DR5 agonist. Inhibrx combines deep scientific and clinical experience with an agile and innovative approach to address unmet medical needs in biotherapeutics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Inhibrx Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Inhibrx Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Inhibrx Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
